Immune status and the immune response to hepatitis B virus vaccine in thalassemic patients after allogeneic bone marrow transplantation

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Bone Marrow Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1700635PMID 9116613
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute hepatitis B infection after vaccination.

  1995cited by this paper
• Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination.

  1995cited by this paper
• Hepatitis B vaccine boosting among young healthy adults.

  1994cited by this paper
• Hepatitis B vaccine boosting among young healthy adults

  1994cited by this paper
• Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation.

  1994cited by this paper
• Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients.

  1993cited by this paper
• Immune response to polio vaccination in bone marrow transplant recipients.

  1991cited by this paper
• Decline of anti-HBs after hepatitis B vaccination and timing of revaccination.

  1990cited by this paper
• Immune recovery after bone marrow transplantation.

  1990cited by this paper
• Bone marrow transplantation in patients with thalassemia.

  1990cited by this paper
• Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases.

  1990cited by this paper
• Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients.

  1990cited by this paper
• Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.

  1989cited by this paper
• PREDICTABILITY BEFORE TRANSPLANT OF HEPATIC COMPLICATIONS FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION

  1989cited by this paper
• Fatal hepatitis B reactivation after autologous bone marrow transplantation.

  1989cited by this paper
• HBsAg carriers among pregnant women in Italy: results from the screening during a vaccination campaign against hepatitis B.

  1988cited by this paper
• Mass vaccination against hepatitis B in infants in Italy.

  1988cited by this paper
• Liver Disease after Human Marrow Transplantation

  1987cited by this paper
• Production in yeast of hepatitis B surface antigen by R-DNA technology.

  1985cited by this paper
• Transfer and persistence of viral antibody-producing cells in bone marrow transplantation.

  1984cited by this paper
• Pneumococcal vaccination of recipients of bone marrow transplants.

  1983cited by this paper
• Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff.

  1981cited by this paper
• Analysis of late infections in 89 long-term survivors of bone marrow transplantation.

  1979cited by this paper
• INTERSTITIAL PNEUMONIA AND CYTOMEGALOVIRUS INFECTION AS COMPLICATIONS OF HUMAN MARROW TRANSPLANTATION1

  1973cited by this paper

• Serologic status and vaccine response against hepatitis B virus after allogeneic hematopoietic cell transplantation in pediatric patients.

  2020influential citation
• Immunological Status of Hepatitis vaccin among B-Thalassemia major patients in Diwaniya

  2017cites this paper
• Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

  2016cites this paper
• Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review

  2015influential citation
• Recombinant Hepatitis B Vaccine (Engerix-B®)

  2012cites this paper
• Enhancing graft-versus-leukemia after transplant: the rise of anti-cancer vaccines.

  2012cites this paper
• Response to Booster Hepatitis B Vaccines in Liver-Transplanted Children Primarily Vaccinated in Infancy

  2008cites this paper
• Early vaccination with tumor-lysate-pulsed dendritic cells after allogeneic bone marrow transplantation has antitumor effects.

  2006cites this paper
• Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants.

  2006cites this paper
• Immune Reconstitution in Pediatric Patients Following Hematopoietic Stem-Cell Transplantation

  2006cites this paper
• Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.

  2004cites this paper
• 68 – Immune Reconstitution

  2004cites this paper
• Sports Med 2004; 34 (9): 555-566

  2004cites this paper
• Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

  2003cites this paper
• 111-117 Immunosuppressive.QXD

  2002cites this paper
• Double‐dose accelerated hepatitis B vaccine in patients with end‐stage liver disease

  2001cites this paper
• Inmunoprofilaxis activa después del trasplante alogénico de progenitores hemopoyéticos en pacientes pediátricos

  2001cites this paper
• DEPARTAMENTO DE PEDIATRÍA, OBSTETRICIA Y GINECOLOGÍA Y MEDICINA PREVENTIVA ÁREA DE PEDIATRÍA RECONSTITUCIÓN INMUNOLÓGICA EN NIÑOS RECEPTORES DE TRASPLANTES DE PROGENITORES HEMATOPOYÉTICOS

  2001cites this paper
• Immunosuppressive Therapy-Induced Hepatotoxicity in Patients with Aplastic Anemia.

  2000cites this paper
• Reimmunization after blood or marrow stem cell transplantation

  1999cites this paper
• Review Reimmunization after blood or marrow stem cell transplantation

  1999cites this paper
• Aluminium chelation in chronic haemodialysis and aluminium adjuvanted vaccines.

  1999cites this paper
• Late complications after bone marrow transplantation in children and adolescents.

  1998cites this paper